Director GULMI CLAIRE M’s Zero‑Price Share Swap Fuels Insider Bullishness at Community Healthcare Trust Inc.

Insider Buying Surge at Community Healthcare Trust Inc. On May 7, 2026, director GULMI CLAIRE M purchased 6,222 shares of Community Healthcare Trust Inc. (CHTI) at a price of $0.00, a zero‑price transaction that mirrors the exchange’s settlement rules but effectively signals a $17.58‑per‑share purchase. The buy increased the director’s holdings to 63,862 shares, representing roughly 12.7 % of the company’s outstanding shares. This move arrives amid a broader wave of insider buying that includes executives such as Cotman Cathrine, Hensley Robert Z, Gardner Alan, and Van Horn R. Lawrence, each adding 6,222 shares in the same filing.

What Does a Zero‑Price Buy Mean for Investors? A zero‑price transaction is typically a “stock‑only” exchange of securities, often used during secondary offerings or internal allocations. For shareholders, it signals confidence: the director is willing to absorb market risk at the current valuation without paying cash. The timing—just a day before the market’s close—suggests an intentional market‑timing strategy, potentially anticipating a modest price uptick. Given the company’s recent 52‑week low of $13.23 and a yearly gain of 7.85 %, the director’s purchase may be interpreted as a bet on sustained mid‑term growth, especially as the firm continues to expand its healthcare asset portfolio.

Insider Activity in Context The June‑2025 to May‑2026 window shows a steady stream of insider purchases: GULMI CLAIRE M’s earlier buys in November 2025, August 2025, May 2025, and March 2025 added 196, 187, 166, and 139 shares respectively, cumulatively building a sizable stake of over 57,000 shares. This pattern indicates a long‑term commitment rather than opportunistic trading. Meanwhile, other executives, such as Stach Leigh Ann and Monroe William G. IV, have engaged in both buys and sells, reflecting a dynamic balance between capital deployment and liquidity management. The collective insider buying volume—nearly 30,000 shares in a single day—suggests a concerted confidence in the company’s strategic trajectory.

Implications for the Future Insider buying is one of the most reliable signals of management belief in a company’s prospects. For CHTI, the sustained accumulation by GULMI CLAIRE M and peers aligns with the firm’s 5.40 % monthly gain and 7.85 % annual return. Analysts may view this as a green light for continued capital expenditures in healthcare facilities, potentially leading to higher earnings per share. However, the zero‑price nature of the transaction could also mask an internal allocation rather than a public purchase, limiting its transparency. Investors should monitor the company’s quarterly reports for any shifts in asset valuations or dividend policies that could affect shareholder value.

A Profile of GULMI CLAIRE M GULMI CLAIRE M has consistently positioned herself as a long‑term holder. Starting with a modest 139‑share purchase in March 2025 at $18.54, her holdings grew incrementally through subsequent purchases, culminating in the current 63,862‑share stake. The pattern shows a preference for buying at market lows—her first buy in May 2025 occurred when the stock traded near $16.04, while her latest acquisition in November 2025 came at $14.58, a 17 % discount to the 52‑week high. This disciplined, patient approach underscores a belief that CHTI’s underlying business model—managing a diversified portfolio of healthcare properties—will deliver steady cash flows. For investors, GULMI CLAIRE M’s activity signals a low‑risk, long‑term investment thesis that could serve as a useful benchmark for evaluating the company’s performance.